should tirzepatide be red Lilly Flags 'Concerning' Impurities in Compounded THIN-ST® (Tirzepatide 15.0mg) – Healthy

This GLP-1 receptor agonist, licensed for type 2 diabetes mellitus treatment in the UK, may trigger dizziness through several mechanisms including hypoglycaemia (particularly when combined with other diabetes medications), dehydration from gastrointestinal effects, or blood pressure changes

Grace periods that followed provided transition windows to help people switch to FDA-approved versions without treatment disruption

11 Consult an endocrinologist for recommendations to bridge antidiabetic therapy if GLP-1 receptor agonists prescribed for diabetes management are to be held for longer than the next scheduled dosing time

Malik, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers